GeoVax Labs

GOVX78

High Growth

$2.78arrow_drop_down2.11%-$0.06

High Growth

Penny Stock

GOVX78

$2.78

arrow_drop_down2.11%-$0.06

High Growth

Penny Stock

Performance History

Key Stats
Open	$2.92
Prev. Close	$2.84
EPS	-13.31
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-
Market Cap	$24.21M
PE Ratio	-

	LOW	HIGH
Day Range	2.72	2.95
52 Week Range	1.09	11.18

Ratios

Revenue	-



EBITDA Margin %	-

EPS	-13.31

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About GeoVax Labs (GOVX)

GeoVax Labs, Inc. (GOVX) is a clinical-stage biotechnology company focused on developing innovative vaccines to prevent and treat infectious diseases. The company's lead product candidate is a preventive vaccine for HIV-1, which is in Phase 2a clinical trials. GOVX's vaccine is designed to stimulate both antibody and T cell immune responses to provide a broad and durable protection against HIV infection.

In addition to its HIV vaccine program, GeoVax Labs is also developing vaccines for other pathogens, including Zika virus, hemorrhagic fever viruses, and malaria. These vaccine candidates are in preclinical development and show promising results in animal studies.

Websitecall_made

Sector: Healthcare
Industry: Biotechnology
CEO: Mr. David Alan Dodd
Headquarters: Smyrna
Employees: 14
Exchange: NASDAQ

Keep an eye on GeoVax Labs

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is the market capitalization of GeoVax Labs (GOVX)?

GeoVax Labs (GOVX) has a market capitalization of $24.21M. The average daily trading volume is 1.33M, indicating the stock's liquidity and investor engagement.

help

What is GeoVax Labs's (GOVX) price per share?

The current price per share for GeoVax Labs (GOVX) is $2.78. The stock has seen a price change of -$0.06 recently, indicating a -2.11% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for GeoVax Labs (GOVX)?

For GeoVax Labs (GOVX), the 52-week high is $11.18, which is 302.16% from the current price. The 52-week low is $1.09, the current price is 155.05% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is GeoVax Labs (GOVX) a growth stock?

GeoVax Labs (GOVX) has shown an average price growth of 0.41% over the past three years. It has received a score of 74 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying GeoVax Labs as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is GeoVax Labs (GOVX) stock price performance year to date (YTD)?

As of the latest data, GeoVax Labs (GOVX) has a year-to-date price change of -49.91%. Over the past month, the stock has experienced a price change of -17.01%. Over the last three months, the change has been 150.45%. Over the past six months, the figure is 49.46%.

help

Is GeoVax Labs (GOVX) a profitable company?

GeoVax Labs (GOVX) has a net income of -$25.97M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -1.68K% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , although specific revenue growth data is currently not available. Operating income is noted at -$26.74M. Furthermore, the EBITDA is -$27.16M.